Cefdinir: Clinical Trials

4 trials of Cefdinir, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 recruiting. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 2, Completed 1, Recruiting 1
Phase 32Completed 1, Unknown 1

Follow Cefdinir: new trials by email Literature Review of Cefdinir trials Research Report on Cefdinir

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-11-12
Single Dose Aminoglycosides for Acute Uncomplicated Cystitis in the Emergency Department Setting
Gentamicin, Standard of Care - Urinary Tract Infections
Phase 2UnknownMercy Health Ohio1602022-10-012023-01-27
The Effect of Chinese Herbal Medicine for Reducing the Application of Antibiotics in the Treatment of Acute Mastitis
CHPM (Chinese Herbal Patent Medicine ), Antibiotics Cefdinir Capsules, Education - Mastitis Acute Female
Phase 2 / Phase 3UnknownBeijing University of Chinese Medicine3062018-12-202020-07-07
Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media
cefdinir - Acute Otitis Media
Phase 2 / Phase 3CompletedAbbott4472002-07-012008-03-27

Conditions studied

Anaphylaxis (1)  ·  Breast Feeding (1)  ·  Drug Hypersensitivity (1)  ·  Hypersensitivity (1)  ·  Otitis Media (1)  ·  Urinary Tract Infections (1)

Sponsors

Abbott (1)  ·  Beijing University of Chinese Medicine (1)  ·  Massachusetts General Hospital (1)  ·  Mercy Health Ohio (1)

Countries

United States (3)  ·  Chile (1)  ·  China (1)  ·  Costa Rica (1)  ·  Dominican Republic (1)  ·  Guatemala (1)  ·  Israel (1)  ·  Panama (1)

Top investigators

David A Khan, MD (1)  ·  Kimberly G Blumenthal, MD, MSc (1)  ·  Xiaohua Pei, MD (1)

Results publications

PMID 38029215

NIH funding

U01AI184071 (1)